An open platform for time-critical workflows
Major biopharmaceutical companies and service providers utilize the Gyros immunoassay platform to boost therapeutic and vaccine development processes. The platform ensures a rapid time to results enabling confident, data-driven decisions and helps to meet increasing regulatory demands
Saving time, labor and sample
Compatible with any immunoassay design, this open platform enables immunoassays to be run, unattended, at nanoliter scale, significantly increasing productivity and efficiency.
New assays are developed in days, rather than the weeks required for conventional approaches. Established assays are readily transferred into the Gyros platform.
High quality data from streamlined assays
As well as minimizing the consumption of samples and reagents, working at nanoliter scale brings significant advantages to assay performance.
Immunoassays at nanoliter scale within a Bioaffy CD
Fully controlled by the Gyrolab xP workstation, Bioaffy CDs process hundreds of samples in parallel under uniform conditions. Each sample is moves rapidly through the integrated steps of the immunoassay, reducing the risk of matrix effects and shortening analysis time.
The CDs available provide a broad dynamic range, from picogram to milligram, minimizing the need for sample dilutions and so lowering sample repeat rates and reducing potential errors that could compromise data quality.
Rexxip buffers, compatible with a variety of molecules with different analytical properties, save time in assay development and help to achieve top immunoassay performance.
Seamless transfer between groups and sites
The automated, operator-independent, process ensures that transfer of established assays within or between sites is a seamless, rapid and highly efficient process.
From research through to GxP environments
Gyrolab software modules for control and data evaluation support 21 CFR part 11 requirements and comprehensive Installation Qualification/Operational Qualification and PQ guidance is available to facilitate regulatory compliance.
